Ruixin micro: the subsidiary waives the preemptive right of Shanghai Hejian to increase its capital in the same proportion

IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

Five Startups Awarded in MYCentre4IR-Bursa Malaysia ESG Innovation Challenge 2024

Highlighting the Role of Innovation in Achieving Sustainability and Business Goals Powered by UpLink, the World Economic Forum's Open Innovation Platform

Brazil raises import tariffs on optical cables, initiates anti-dumping probe

CRSC Wins Eight Significant Bids with Total Value of CNY 2.17 Bn

CRSC wins two bids on the railway system market and six bids on the urban railway market in recent two months, which is likely to help the company achieve growth again in Q4 2020 and fiscal year 2021.

Does Dual-listed CRSC Create a Room for Arbitrage Deals?

One of the largest China's rail transit related systems manufacturers is now listed both on HKEX and the Star Market. Let's track the two stocks' performance.